ENGN

1.6953.69%
PD

Paul D. Robbins

Chairman of Scientific Advisory Board

Dr. Paul D. Robbins, Ph.D., is a Professor of Molecular Genetics and Biochemistry and Orthopaedic Surgery at the University of Pittsburgh School of Medicine. Dr. Robbins serves as Director of the Vector Core Facility and Director of Basic Research for the Molecular Medicine Institute. Dr. Robbins is a pioneer and world-renowned leader in innovative gene delivery technologies. Dr. Robbins also acts as consultant to several well-established gene therapy companies including Cell Genesys and Valentis Corporation. He serves as the Chairman of Scientific Advisory Board of enGene Therapeutics Inc. (formerly known as enGene Holdings Inc.) (formerly known as enGene, Inc.) He is an Associate Editor for Cancer Research and Gene Therapy as well as on the Editorial Boards for Cancer Gene Therapy, The Journal of Gene Medicine, Arthritis Research, and Genes & Immunity. He worked as a post-doctoral fellow at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology. He served as a Member of Scientific Advisory Board of Kolon TissueGene, Inc until 2019. He is a member of the PathB Study Section, the Italian Telethon Scientific Review Committee, the Scientific Review Board of National Gene Vector Laboratory as well as former Chair of the American Society of Gene Therapy Committee on Musculoskeletal Diseases. Dr. Robbins has co-authored over 230 peer-reviewed manuscripts and 130 book chapters and reviews and has edited two books on gene therapy. His research programs attract considerable public and private funding and he has generated over 390 scientific articles and 23 patent applications in the field of gene therapy. He is involved with the Juvenile Diabetes Research Foundation and American Diabetes Association on several projects. Dr. Robbins received his B.A. from Haverford College and his Ph.D. from the University of California at Berkeley.

Positions